Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment

The Journal of Clinical Psychiatry
Stephen BlankCharles F Reynolds

Abstract

Anxiety disorders are common in later life, but little is known about the long-term benefits and risks of pharmacotherapy. 30 patients aged 60 years and older, with a DSM-IV anxiety disorder, entered a 32-week trial of citalopram. Data gathered at baseline and follow-up included anxiety symptoms using Hamilton Rating Scale for Anxiety (HAM-A) scores, quality of life using the Medical Outcomes Study 36-item Short Form (SF-36), and sleep using the Pittsburgh Sleep Quality Index (PSQI). Data analysis consisted of mixed-effect repeated measures models of HAM-A scores and pre-post comparison of SF-36 and PSQI scores. 30 persons entered treatment; most (27/30) had a primary DSM-IV diagnosis of generalized anxiety disorder (2 had panic disorder; 1 had posttraumatic stress disorder). Three subjects discontinued study medication due to side effects, 5 were terminated because of nonresponse, and 5 dropped out of the study for other reasons; thus, 17 subjects (57%) completed 32 weeks of treatment. Subjects' HAM-A scores improved significantly, with continuing improvements up until about 20 weeks of treatment. On the basis of a criterion of reduction in HAM-A to < 10 during the trial, 60% (18/30) of subjects were responders. Those who comp...Continue Reading

Citations

Nov 19, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Stefan G HofmannJamie Sturm
Aug 12, 2014·Health Technology Assessment : HTA·Samantha BartonSteven J Edwards
Jan 22, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Adam P SpiraKristine Yaffe
Jun 1, 2008·Sleep Medicine Clinics·Thomas A Mellman
Nov 23, 2006·The Psychiatric Clinics of North America·Thomas A Mellman
Sep 28, 2010·International Journal of Geriatric Psychiatry·Julie Loebach WetherellEric J Lenze
Jul 13, 2011·The Mount Sinai Journal of Medicine, New York·Erin K Kastenschmidt, Gary J Kennedy
Oct 4, 2008·Journal of Psychopharmacology·J R DavidsonM Versiani
Oct 20, 2017·The Cochrane Database of Systematic Reviews·Taryn WilliamsDan J Stein
Jul 12, 2019·The Mental Health Clinician·Jamie L McCarrellAmie Taggart Blaszczyk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.